Core Insights - Tilray (TLRY) reported improved financial performance for Q2-2026, with increased revenues and a reduced net loss, primarily driven by international cannabis sales [1] Financial Performance - Revenues increased significantly, contributing to the overall improvement in financial health [1] - The net loss showed improvement, indicating better cost management and operational efficiency [1] Market Strategy - Tilray reaffirmed its commitment to entering the US cannabis market, contingent upon rescheduling regulations [1]

Investor Presentation September 30, 2025 CAUTIONARY STATEMENT This document is current as of September 30, 2025, except where otherwise stated. The information contained in this presentation is provided by Organigram Global Inc. ("Organigram" or the "Company") for informational purposes only and does not constitute an offer to issue or arrange to issue, or the solicitation of an offer to issue, securities of Organigram or other financial products. No part of this presentation shall form the basis or be reli ...